Clinical trials
Phase 1/2 Lymphoma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
| Completed | 5 |
| Terminated | 4 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CRISPR Therapeutics AG | 2 |
| Allogene Therapeutics | 1 |
| AstraZeneca | 1 |
| Australian & New Zealand Children's Haematology/Oncology Group | 1 |
| Bristol-Myers Squibb | 1 |
| Children's Oncology Group | 1 |
| Dren Bio | 1 |
| Hoffmann-La Roche | 1 |
| IGM Biosciences, Inc. | 1 |
| Lyell Immunopharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 18 |
| Leukemia | 6 |
| Lymphoma, Non-Hodgkin | 6 |
| Recurrence | 6 |
| Lymphoma, B-Cell | 4 |
| Lymphoma, Follicular | 4 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Glioma | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, Mantle-Cell | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.